DE2503222A1 - PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVES - Google Patents
PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVESInfo
- Publication number
- DE2503222A1 DE2503222A1 DE19752503222 DE2503222A DE2503222A1 DE 2503222 A1 DE2503222 A1 DE 2503222A1 DE 19752503222 DE19752503222 DE 19752503222 DE 2503222 A DE2503222 A DE 2503222A DE 2503222 A1 DE2503222 A1 DE 2503222A1
- Authority
- DE
- Germany
- Prior art keywords
- radical
- group
- atoms
- tert
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/64—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Verfahren zur Herstellung von l-Aryloxy-3-N-substituierten Aminopropanderivaten Die Erfindung betrifft ein Verfahren zur Herstellung von 1-Aryloxy-3-N-substituierten Aminopropanderivaten der allgemeinen Formel sowie deren physiologisch verträglichen Säureadditionssalzen.Process for the preparation of 1-aryloxy-3-N-substituted aminopropane derivatives The invention relates to a process for the preparation of 1-aryloxy-3-N-substituted aminopropane derivatives of the general formula and their physiologically compatible acid addition salts.
In dieser Formel bedeuten R1 ein Halogenatom, eine Alkylgruppe mit 5-8 C-Atomen, eine Alkenyl- oder Alkinylgruppe mit 2-6 C-Atomen, einen Rest mit der Reilformel -(CH2)x-CN,-(CH2)y-NH2 oder -(CH2)y-OH, wobei x Null oder eine ganze Zahl von 1-3, y eine ganze Zahl von 1-3 bedeutet, eine Carboxylgruppe, einen niederen Alkylamino- oder Dialkylaminorest, einen Alkoxyalkylrest mit 2-6 C-Atomen, einen Tetrahydrofurylalkoxyrest oder einen Furylalkoxyrest mit niederem Alkoxyteil, einen Thienylrest, den Rest COOR6 (wobei R6 einen Alkylrest mit 1-4 C-Atomen bedeutet) einen Alkinyloxyrest mit 3-6 C-Atomen, einen niederen aliphatischen, araliphatischen oder aromatischen Acyl- oder Acyloxyrest, einen Cycloalkylrest mit 3-7 C-Atomen, eine Nitro- oder Carbonamidogruppe, die Gruppe -NH-CO-NHR7R8, wobei R7 und R8 Wasserstoff, niederes Alkyl oder zusammen mit dem N-Atom einen Heterocyclus wie den Pyrrolidino-, Piperidino- oder Morpholinorest bedeutet oder einen ggf. mit Halogen, niederem Alkyl, einer Nitro-, Cyano-oder Carboxygruppe substituierten Aryl- oder Aryloxy-(vorzugsweise Phenyl- oder Phenoxy-)-rest, ein Wasserstoff- oder ein Halogenatom, eine Alkenylgruppe .niet 2-4 C-Atomen, eine Alkyl- oder Alkoxygruppe mit 1-4 C-Atomen, eine Cyano-, Amino-, Hydroxy- oder Nitrogruppe oder eine niedere Acylaminogruppe, R3 ein Wasserstoff- oder ein Halogenatom, eine Alkyl- oder Alkoxygruppe mit 1-4 C-Atomen oder zusammen mit R2 die Gruppierung - CH=CH-CH=CH- oder -(CH2)n- (n= ganze Zahl von 3-5) mit Bindung der freien Valenzen in o-Stellung zueinander, R4 einen gesättigten oder ungesättigten, ggf. mit OH oder Halqgen substituierten Alkylrest mit 2-8 C-Atomen, einen Alkylcycloalkylrest mit 4-10 C-Atomen, einen Cycloalkylrest mit 3-7 C-Atomen, einen Aralkylrest oder einen Aryloxyalkylrest mit niederem Alkylteil, R ein Wasserstoffatom, einen niederen aliphatischen oder.In this formula, R1 denotes a halogen atom, an alkyl group with 5-8 carbon atoms, an alkenyl or alkynyl group with 2-6 carbon atoms, one radical with the formula - (CH2) x-CN, - (CH2) y-NH2 or - (CH2) y-OH, where x zero or an integer from 1-3, y is an integer from 1-3, a carboxyl group, a lower alkylamino or dialkylamino radical, an alkoxyalkyl radical with 2-6 C atoms, a tetrahydrofurylalkoxy radical or a furylalkoxy radical with lower Alkoxy part, a thienyl radical, the radical COOR6 (where R6 is an alkyl radical with 1-4 C atoms means) an alkynyloxy radical with 3-6 C atoms, a lower aliphatic, araliphatic or aromatic acyl or acyloxy radical, a cycloalkyl radical with 3-7 carbon atoms, a nitro or carbonamido group, the group -NH-CO-NHR7R8, where R7 and R8 are hydrogen, lower alkyl or, together with the N atom, form a heterocycle such as the pyrrolidino, piperidino or morpholino radical or optionally with Halogen, lower alkyl, a nitro, cyano or carboxy group substituted aryl or aryloxy (preferably phenyl or phenoxy) radical, a hydrogen or a Halogen atom, an alkenyl group .niet 2-4 C atoms, an alkyl or alkoxy group with 1-4 carbon atoms, a cyano, amino, hydroxyl or nitro group or a lower one Acylamino group, R3 is a hydrogen or a halogen atom, an alkyl or alkoxy group with 1-4 carbon atoms or together with R2 the grouping - CH = CH-CH = CH- or - (CH2) n- (n = whole number from 3-5) with binding of the free valences in the o-position to one another, R4 is a saturated or unsaturated one, optionally substituted with OH or Halqgen An alkyl radical with 2-8 carbon atoms, an alkylcycloalkyl radical with 4-10 carbon atoms, a cycloalkyl radical with 3-7 carbon atoms, an aralkyl radical or an aryloxyalkyl radical with a lower alkyl part, R. a hydrogen atom, a lower aliphatic or.
aromatischen Acylrest oder den Tetrahydropyranylrest.aromatic acyl radical or the tetrahydropyranyl radical.
Wenn R1 einen niederen aliphatischen Acylrest bedeutet, so kommt hierfür beispielsweise der Acetyl-, Propionyl- oder Butyryl- bzw. Isobutyrylrest infrage. Als araliphatischer Acylrest kann R1 beispielsweise den Phenacetylrest, der ggf.If R1 is a lower aliphatic acyl radical, this is the case for example the acetyl, propionyl or butyryl or isobutyryl radical in question. As an araliphatic acyl radical, R1 can be, for example, the phenacetyl radical, which may be
am Phenyl mit einemoder mehreren Halogenatomen, Alkylgruppen, Nitro-, Cyano- oder Carboxylgrupnen substituiert ist bedeuten.on phenyl with one or more halogen atoms, alkyl groups, nitro, Cyano or carboxyl groups are substituted.
In der Bedeutung aromatisches Acyl kann R1 beispielsweise einen ggf. mit Halogen, niederem Alkyl, Nitro, Cyano oder.In the meaning of aromatic acyl, R1 can, for example, be an optionally with halogen, lower alkyl, nitro, cyano or.
Carboxyl ein oder mehrfach substituierten-Benzoylrest bedeuten.Carboxyl means one or more substituted benzoyl radicals.
Stellt R1 einen Acyloxyrest dar, so kann der Acylrest darin ebenfalls durch die im vorstehenden Absatz einzeln aufgeführten Acylgruppen verkörpert werden.If R1 represents an acyloxy radical, the acyl radical therein can likewise are embodied by the acyl groups listed individually in the preceding paragraph.
8ie Verbindungen der allgemeinen Formel I bzw. deren Salze stellen wertvolle Pharmazeutika mit ß-adrenolytischer Wirkung dar. Sie können daher beispielsweise zur Behandlung oder Prophylaxe von Erkrankungen der Herzkranzgefäße und zur Behandlung von Herzarrhythmien, insbesondere von Tachycardien, in der Humanmedizin eingesetzt werden. Auch die blutdrucksenkenden Eigenschaften der Verbindungen sind therapeutisch interessant.The compounds of general formula I or their salts represent valuable pharmaceuticals with ß-adrenolytic effect. You can therefore, for example for the treatment or prophylaxis of diseases of the coronary arteries and for the treatment of cardiac arrhythmias, in particular of tachycardias, used in human medicine will. The antihypertensive properties of the compounds are also therapeutic Interesting.
Die Verbindungen der allgemeinen Formel I werden erfindungsgemäß so hergestellt, daß ein Phenol der allgemeinen Formel II in welcher R1 bis R3 die obengenannte Bedeutung haben, oder ein Salz dieses Phenols mit einem Azetidinolderivat der allgemeinen Formel in welcher R4 und R die obengenannte Bedeutung haben, in 5 wasserfreiem Medium umgesetzt wird. Sollen solche Endprodukte gewonnen werden, bei denen R5= H ist (l-Aryloxy-2-hydroxy-3-N-subst. Aininopropane), so kann die Reaktion auch so durchgeführt werden, daß zunächst eine Verbindung der allgemeinen Formel III eingesetzt wird, bei der R5 von Wasserstoff verschieden ist, und anschließend aus dem Reaktionsprodukt die Gruppe R5 in an sich bekannter Weise (beispielsweise durch Verseifen oder Abhydrieren) entfernt wird.According to the invention, the compounds of the general formula I are prepared in such a way that a phenol of the general formula II in which R1 to R3 have the abovementioned meaning, or a salt of this phenol with an azetidinol derivative of the general formula in which R4 and R have the abovementioned meaning, is reacted in an anhydrous medium. If end products are to be obtained in which R5 = H (l-aryloxy-2-hydroxy-3-N-substituted aminopropane), the reaction can also be carried out in such a way that a compound of the general formula III is used first, in which R5 is different from hydrogen, and then the group R5 is removed from the reaction product in a manner known per se (for example by saponification or hydrogenation).
Die Ausgangsphenole der allgemeinen Formel II sind bekannt.The starting phenols of the general formula II are known.
£)ie Azetidinole der allgemeinen Formel III können nach literaturbekannten Methoden (s. beispielsweise Chem. Pharm.£) The azetidinols of the general formula III can be used according to the literature Methods (see for example Chem. Pharm.
Bull (Japan) Vol. 22 (7), 1974 (Seite 1490) hergestellt werden.Bull (Japan) Vol. 22 (7), 1974 (page 1490).
Das neue Verfahren führt in einer Einstufenreaktion direkt zum gewünschten Endprodukt der allgemeinen Formel I, das stets in hohen Ausbeuten und großer Reinheit anfällt, da Nebenreaktionen nicht auftreten. Besonders vorteilhaft lassen sich solche Verbindungen der allgemeinen Formel I herstellen, bei denen R1 einen ungesättigten Rest wie CN, eine Alkenyl-, oder Alkinylgruppe, R4 eine niedere Allylgruppe und R2, R3 und R5 Wasserstoff bedeuten, insbesondere das l-(2-Cyanophenoxy)-2-hydroxy- 3- isopropylaminopropan und das 1-(2-Cyanophenoxy)-2-hydroxy-3-tert. butylaminopropan. Auch die Herstellung der Verbindung 1 [2-Tetrahydrofurylmethoxy (phenoxy)]-2-hydroxy-3-tert. butylaminopropan gelingt nach dem erfindungsgemäßen Verfahren besonders gut.The new process leads directly to the desired result in a one-step reaction End product of general formula I, always in high yields and great purity arises because side reactions do not occur. Those can be particularly advantageous Preparing compounds of the general formula I in which R1 is an unsaturated Remainder such as CN, an alkenyl or alkynyl group, R4 a lower allyl group and R2, R3 and R5 are hydrogen, in particular the 1- (2-cyanophenoxy) -2-hydroxy- 3- isopropylaminopropane and 1- (2-cyanophenoxy) -2-hydroxy-3-tert. butylaminopropane. The preparation of the compound 1 [2-tetrahydrofurylmethoxy (phenoxy)] - 2-hydroxy-3-tert. butylaminopropane works particularly well with the process according to the invention.
Die erfindungsgemäßen Verbindungen besitzen ein asymmetrisches C-Atom an der CHOH-Gruppe und kommen daher als Racemat wie auch in Form der optischen Antipoden vor. Letztere können außer durch Racematentrennung mit üblichen Hilfssäuren wie Dibenzoyl-(bzw. Di-p-Toluyl- )D-Weinsäure oder, D- 3-Bromcampher-8- sulfonsäure auch durch Einsetzen von optisch aktivem Ausgangsmaterial erhalten werden.The compounds according to the invention have an asymmetric carbon atom on the CHOH group and therefore come as a racemate as well as in the form of the optical antipodes before. The latter can in addition to by resolution with customary auxiliary acids such as Dibenzoyl (or di-p-toluyl) D-tartaric acid or D-3-bromocamphor-8-sulfonic acid can also be obtained by employing optically active starting material.
Die er t'indungsgemäßen 1-Phenoxy-2-hydroxy-3-aminopropane der allgemeinen Formel I können in üblicher Weise in ihre ph-siologisch verträglichen Säureadditionssalze überführt werden. Geeignete Säuren sind beispielsweise Salzsäure, Bromwasserstoffsäure, Schwefelsäure, Methansulfonsäure, oleinsäure, Essigsäure, Oxalsäure, Milchsäure, Weinsäure oder 8-Chlortheophyllin.The 1-phenoxy-2-hydroxy-3-aminopropanes according to the general Formula I can be converted into their ph-siologically acceptable acid addition salts in the customary manner be convicted. Suitable acids are, for example, hydrochloric acid, hydrobromic acid, Sulfuric acid, methanesulfonic acid, oleic acid, acetic acid, oxalic acid, lactic acid, Tartaric acid or 8-chlorotheophylline.
Die nachfolgenden Beispiele erläutern die Erfindung, ohne sie zu beschränken.The following examples explain the invention without restricting it.
Beispiel 1 1-(2-Cyanophenoxy)-3-sec. butylamino-3-propanol. HCl 3,22 g (0,025 Mol 1-sec. Butyl-azetidinol-3-werden in 20 ml Benzylalkohol gelöst, 3,5 g (0,03 Mol) 2-Cyanophenol und 100 mg KOH zugegeben und unter Rühren im Stickstoffstrom 6 Stunden auf 1400 erhitzt. Nach Abkühlen und Stehen über Nacht werden 0 ml Äther zugegeben. Das Ganze wird zweimal mit je 30 ml 1 n HC1 ausgeschüttelt. Die vereinigten wäßrigen Phasen werden mit Äther gewaschen und mit NaOH alkalisch gestellt. Die ausfallenden basischen Anteile werden mit Äther extrahiert. Nach Trocknen der organischen Phase über MgSO4 wird der Äther abdestilliert. Der verbleibende Rückstand (4,3 g) wird mit Äther gelöst und mit alkoholischer HC1 angesäuert. Das sich abscheidende ölige Produkt wird mit Äther verrieben, wobei es sich kristallin verfestigt. Nach Umkristallisation aus Äthanol unter Zugabe von Äther werden 2,-, g farbloses Kristallisat vom Schmelzpunkt Fp: 117-119° -r klalten .Example 1 1- (2-Cyanophenoxy) -3-sec. butylamino-3-propanol. HCl 3.22 g (0.025 mol of 1-sec. Butyl-azetidinol-3-are dissolved in 20 ml of benzyl alcohol, 3.5 g (0.03 mol) of 2-cyanophenol and 100 mg of KOH were added and stirring was carried out in a stream of nitrogen Heated to 1400 for 6 hours. After cooling and standing overnight, 0 ml of ether are added admitted. The whole thing is extracted twice with 30 ml of 1N HC1 each time. The United aqueous phases are washed with ether and made alkaline with NaOH. the precipitating basic components are extracted with ether. After drying the organic Phase over MgSO4, the ether is distilled off. The remaining residue (4.3 g) is dissolved with ether and acidified with alcoholic HC1. The separating Oily product is rubbed with ether, where it solidifies in crystalline form. To Recrystallization from ethanol with the addition of ether becomes 2, -, g of colorless crystals melting point: 117-119 ° -r klalten.
in Analogie zu beispiel 1 wurden noch folgende Verbindungen der Formel
I erhalten:
beispiel 3 1- (2-Cyanophenoxy)- 3-tert. butylamino-3-propanol # HC1 7 g (0,054 Mol) l-tert. Butyl-5-azetidinol werden in 30 ml Benzylalkohol gelöst und 7,2 g (0,06 Mol) 2-Cyanophenol sowie 0,3 g KOH zugegeben. Das Ganze wird unter Rühren im Stickstoffstrom 6 Stunden auf 1400 erhitzt. Nach Abkühlung werden 100 ml Äther zugegeben und durch dreimaliges Ausschütteln mit je 40 ml 2 n HCl werden die basischen Produkte extrahiert. Die saure wäßrige Phase wird mit Äther gewaschen und mit NaOH alkalisch gestellt. Die Ausfallenden basischen Anteile werden in Äther aufgenommen; die organische Phase wird mit Wasser gewaschen.Example 3 1- (2-Cyanophenoxy) - 3-tert. butylamino-3-propanol # HC1 7 g (0.054 mol) of l-tert. Butyl-5-azetidinol are dissolved in 30 ml of benzyl alcohol and 7.2 g (0.06 mol) of 2-cyanophenol and 0.3 g of KOH were added. The whole thing is under Stirring heated to 1400 for 6 hours in a stream of nitrogen. After cooling it will be 100 ml of ether are added and by shaking out three times with 40 ml of 2N HCl each time the basic products are extracted. The acidic aqueous phase is washed with ether and made alkaline with NaOH. The precipitating basic parts are in ether recorded; the organic phase is washed with water.
Nach Trocknung über MgSO4 wird der Äther abdestilliert und der verbleibende Rückstand (8,2 g) in Äther gelöst. Durch Zugabe von alkoholischer HC1 wird das Hydrochlorid kristallin abgeschieden. Es wird aus Äthanol unter Zugabe von Äther umkristallisiert. Nach Trocknung erhält man 7,1 g farbloses Kristallisat vom Fp: 34,4 - 155,5°.After drying over MgSO4, the ether is distilled off and the remaining one Residue (8.2 g) dissolved in ether. The hydrochloride is formed by adding alcoholic HC1 deposited in crystalline form. It is made from ethanol with the addition of ether recrystallized. After drying, 7.1 g of colorless crystals with a melting point of: 34.4-155.5 degrees.
in Analogie zu den ei spielen 2 und 3 wurden noch folgende Verbindungen
der Formel 1 synthetisiert:
In Analogie zu Beispiel 4 wurden noch folgende Verbindungen der Formel
I hergestellt:
In Analogie zu Beispiel 5 wurden noch folgende Verbindungen der Formel
I erhalten:
Claims (1)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752503222 DE2503222A1 (en) | 1975-01-27 | 1975-01-27 | PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVES |
AT939075A AT340389B (en) | 1975-01-27 | 1975-12-11 | PROCESS FOR THE PREPARATION OF 1-CYANOPHENOXY-2-HYDROXY-3-AMINOPROPANES AND THEIR ACID ADDITION SALTS |
FI753667A FI753667A (en) | 1975-01-27 | 1975-12-29 | |
GR49822A GR59280B (en) | 1975-01-27 | 1976-01-20 | Process for the preparation of 1-aryloxy-3-n-substituted aminopropane derivatives |
LU74246A LU74246A1 (en) | 1975-01-27 | 1976-01-26 | |
JP51007427A JPS51125334A (en) | 1975-01-27 | 1976-01-26 | Process for preparing 11aryloxyy33nn substituted aminopropane derivatives |
CH91476A CH623024A5 (en) | 1975-01-27 | 1976-01-26 | Process for the preparation of 1-aryloxy-3-N-(substituted)aminopropanes |
DK29376*#A DK29376A (en) | 1975-01-27 | 1976-01-26 | PROCEDURE FOR PREPARING 1-ARYLOXY-3-N-SUBSTITUTED AMINOPROPANE DERIVATIVES |
ES444611A ES444611A1 (en) | 1975-01-27 | 1976-01-26 | Procedure for the preparation of aminopropanos replaced in position 1 with ariloxi and in position 3 in n. (Machine-translation by Google Translate, not legally binding) |
NO760239A NO760239L (en) | 1975-01-27 | 1976-01-26 | |
SE7600846A SE7600846L (en) | 1975-01-27 | 1976-01-27 | PROCEDURE FOR PREPARING 1-ARYLOXY-3-N-SUBSTITUTED AMINOPROPANE DERIVATIVES |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752503222 DE2503222A1 (en) | 1975-01-27 | 1975-01-27 | PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVES |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2503222A1 true DE2503222A1 (en) | 1976-07-29 |
Family
ID=5937398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19752503222 Withdrawn DE2503222A1 (en) | 1975-01-27 | 1975-01-27 | PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVES |
Country Status (11)
Country | Link |
---|---|
JP (1) | JPS51125334A (en) |
AT (1) | AT340389B (en) |
CH (1) | CH623024A5 (en) |
DE (1) | DE2503222A1 (en) |
DK (1) | DK29376A (en) |
ES (1) | ES444611A1 (en) |
FI (1) | FI753667A (en) |
GR (1) | GR59280B (en) |
LU (1) | LU74246A1 (en) |
NO (1) | NO760239L (en) |
SE (1) | SE7600846L (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2644833A1 (en) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE AMINOPROPANES AND METHOD FOR THE PRODUCTION THEREOF |
EP0073011A1 (en) * | 1981-08-26 | 1983-03-02 | Boehringer Ingelheim Kg | 1-Aryloxy-3-alkinyl-amino-2-propanols and a method for their preparation |
EP0073016A1 (en) * | 1981-08-26 | 1983-03-02 | Boehringer Ingelheim Kg | 1-Aryloxy-3-alkylamino-2-propanols and processes for their preparation |
EP0038936B1 (en) * | 1980-04-25 | 1983-04-27 | C.H. Boehringer Sohn | Derivatives of 1-aryloxy-3-alkylamino-2-propanol and methods for their preparation |
US4652584A (en) * | 1984-07-13 | 1987-03-24 | Mcneilab, Inc. | Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension |
US4663334A (en) * | 1985-12-11 | 1987-05-05 | Mcneilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
GB2190084A (en) * | 1984-03-02 | 1987-11-11 | Roehm Pharma Gmbh | Benzyl cyanides |
US4728666A (en) * | 1985-12-11 | 1988-03-01 | Mcneilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
WO1989005795A1 (en) * | 1987-12-23 | 1989-06-29 | Aktiebolaget Hässle | Novel antiarrhythmic agents ii |
US4892886A (en) * | 1987-07-21 | 1990-01-09 | Hoffman-La Roche Inc. | Phenoxypropanolamines |
US5064863A (en) * | 1983-10-19 | 1991-11-12 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical use |
JPH04502980A (en) * | 1988-11-17 | 1992-05-28 | フィジカル サイエンシーズ インコーポレーテッド | Electrocatalysts, methods of manufacturing them, electrodes manufactured therefrom and methods of using them |
US5166218A (en) * | 1983-10-19 | 1992-11-24 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical compositions thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2779240B2 (en) * | 1987-12-11 | 1998-07-23 | 三井化学株式会社 | New amines and their uses |
US4969332A (en) * | 1989-01-27 | 1990-11-13 | Allied-Signal, Inc. | Controller for a three-wheel turbocharger |
-
1975
- 1975-01-27 DE DE19752503222 patent/DE2503222A1/en not_active Withdrawn
- 1975-12-11 AT AT939075A patent/AT340389B/en not_active IP Right Cessation
- 1975-12-29 FI FI753667A patent/FI753667A/fi not_active Application Discontinuation
-
1976
- 1976-01-20 GR GR49822A patent/GR59280B/en unknown
- 1976-01-26 DK DK29376*#A patent/DK29376A/en unknown
- 1976-01-26 NO NO760239A patent/NO760239L/no unknown
- 1976-01-26 ES ES444611A patent/ES444611A1/en not_active Expired
- 1976-01-26 CH CH91476A patent/CH623024A5/en not_active IP Right Cessation
- 1976-01-26 JP JP51007427A patent/JPS51125334A/en active Pending
- 1976-01-26 LU LU74246A patent/LU74246A1/xx unknown
- 1976-01-27 SE SE7600846A patent/SE7600846L/en not_active Application Discontinuation
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2644833A1 (en) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | NEW 1-ARYLOXY-2-HYDROXY-3-ALKYLENE AMINOPROPANES AND METHOD FOR THE PRODUCTION THEREOF |
EP0038936B1 (en) * | 1980-04-25 | 1983-04-27 | C.H. Boehringer Sohn | Derivatives of 1-aryloxy-3-alkylamino-2-propanol and methods for their preparation |
US4438143A (en) | 1980-04-25 | 1984-03-20 | Boehringer Ingelheim Kg | 1-Aryloxy-3-alkylamino-2-propanols and pharmaceutical compositions containing them |
EP0073011A1 (en) * | 1981-08-26 | 1983-03-02 | Boehringer Ingelheim Kg | 1-Aryloxy-3-alkinyl-amino-2-propanols and a method for their preparation |
EP0073016A1 (en) * | 1981-08-26 | 1983-03-02 | Boehringer Ingelheim Kg | 1-Aryloxy-3-alkylamino-2-propanols and processes for their preparation |
US5166218A (en) * | 1983-10-19 | 1992-11-24 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical compositions thereof |
US5064863A (en) * | 1983-10-19 | 1991-11-12 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical use |
GB2190084A (en) * | 1984-03-02 | 1987-11-11 | Roehm Pharma Gmbh | Benzyl cyanides |
US4652584A (en) * | 1984-07-13 | 1987-03-24 | Mcneilab, Inc. | Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension |
EP0226447A2 (en) * | 1985-12-11 | 1987-06-24 | McNeilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
US4728666A (en) * | 1985-12-11 | 1988-03-01 | Mcneilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
EP0226447A3 (en) * | 1985-12-11 | 1988-08-31 | McNeilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
US4663334A (en) * | 1985-12-11 | 1987-05-05 | Mcneilab, Inc. | Heteroaromatic acetylenes useful as antihypertensive agents |
US4892886A (en) * | 1987-07-21 | 1990-01-09 | Hoffman-La Roche Inc. | Phenoxypropanolamines |
WO1989005795A1 (en) * | 1987-12-23 | 1989-06-29 | Aktiebolaget Hässle | Novel antiarrhythmic agents ii |
WO1989005794A1 (en) * | 1987-12-23 | 1989-06-29 | Aktiebolaget Hässle | Novel antiarrhythmic agents i |
US5034411A (en) * | 1987-12-23 | 1991-07-23 | Aktiebolaget Hassle | Novel 4-cyanophenyl derivatives with action against cardiac arrhythmia |
US5155133A (en) * | 1987-12-23 | 1992-10-13 | Aktiebolaget Hassle | Antiarrhythmic compounds and pharmaceutical compositions and methods thereof |
JPH04502980A (en) * | 1988-11-17 | 1992-05-28 | フィジカル サイエンシーズ インコーポレーテッド | Electrocatalysts, methods of manufacturing them, electrodes manufactured therefrom and methods of using them |
Also Published As
Publication number | Publication date |
---|---|
AT340389B (en) | 1977-12-12 |
ES444611A1 (en) | 1977-05-01 |
JPS51125334A (en) | 1976-11-01 |
FI753667A (en) | 1976-07-28 |
NO760239L (en) | 1976-07-28 |
DK29376A (en) | 1976-07-28 |
GR59280B (en) | 1977-12-06 |
CH623024A5 (en) | 1981-05-15 |
LU74246A1 (en) | 1977-03-18 |
SE7600846L (en) | 1976-07-27 |
ATA939075A (en) | 1977-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2503222A1 (en) | PROCESS FOR THE PREPARATION OF 1-ARYL-OXY-3-N-SUBSTITUTED AMINOPROPAN DERIVATIVES | |
DE3026201A1 (en) | AMINOAETHEROXIDE, METHOD FOR THE PRODUCTION THEREOF AND THEIR THERAPEUTIC USE | |
DE69120899T2 (en) | New N-benzoylproline derivatives, production processes and medicinal products containing them | |
CH637130A5 (en) | CHINAZOLINE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE OF THESE DERIVATIVES IN MEDICINAL PRODUCTS. | |
DE2807623C2 (en) | 2-Phenoxyphenyl-pyrrolidine derivatives, their salts, processes for their production and pharmaceutical preparations containing them | |
DE68912860T2 (en) | 1 - [(Diarylmethoxy) alkyl] pyrrolidines and piperidines, process for their preparation and medicaments containing them. | |
EP0090369B1 (en) | Salicylic-acid derivatives, process for their preparation, pharmaceutical preparations based on these compounds and their use | |
DE3942729A1 (en) | Novel capsaicin derivs. | |
DE2515146A1 (en) | Hypolipemic carboxylic-amides - such as N-isovaleryl N,N'-bis-(10-undecenoyl) ethylene-diamine | |
DE69919860T2 (en) | 2-METHYLPROPIONIC ACID DERIVATIVES AND MEDICAL PREPARATIONS CONTAINING THEM | |
DD295344A5 (en) | benzanilides | |
DE68906122T2 (en) | Compounds for the treatment of urinary incontinence. | |
EP0271099A2 (en) | Substituted aminopropionic acid amides, process for their preparation, agents containing them and their use as well as the intermediates formed during the preparation | |
CH637107A5 (en) | Process for preparing novel 1-aryloxy-2-hydroxy-3-aminopropanes | |
DD300542A5 (en) | CHEMICAL COMPOUNDS | |
US4333930A (en) | Orthoarylideneaminophenethylamines and pharmaceutical compositions | |
DE2354931C2 (en) | trans-2-phenylbicyclooctane compounds, processes for their preparation and pharmaceutical preparations containing them | |
DD298786A5 (en) | thiophenes | |
EP0664788A1 (en) | Substituted ethanolamine esters | |
CH647235A5 (en) | 4- (2,2-DIALKYLINDAN-1-YLIDEN) PIPERIDINE DERIVATIVES, THEIR PRODUCTION AND USE. | |
DE3237149A1 (en) | 5-AMINOISOXAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC PREPARATIONS CONTAINING THESE COMPOUNDS | |
CH535767A (en) | 1-phenethyl-4-arylamino-piperidines - with analgesic activity | |
DD151447A1 (en) | PROCESS FOR THE PREPARATION OF AMIDINES AND THEIR SALTS | |
DD149664A5 (en) | PROCESS FOR PRODUCING 1,1'-BIPHENYL-2-YL-ALKYLAMINE DERIVATIVES | |
AT205980B (en) | Process for the preparation of new phenothiazine derivatives substituted in the 3-position by a monovalent sulfur function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8141 | Disposal/no request for examination |